Lista de obras -

(111)In-trastuzumab scintigraphy in HER2-positive metastatic breast cancer patients remains feasible during trastuzumab treatment.

artículo científico publicado en 2014

(89)Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

artículo científico publicado en 2009

18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer

artículo científico publicado en 2017

18F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients

artículo científico publicado en 2018

89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.

artículo científico publicado en 2017

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

scientific article published on 26 November 2018

89Zr-bevacizumab PET imaging in primary breast cancer

artículo científico publicado en 2013

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

artículo científico publicado en 2010

89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake

artículo científico publicado en 2019

89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.

artículo científico publicado en 2014

A 21-year-old patient with a HER2-positive colorectal cancer

artículo científico publicado en 2014

Abstract OT3-2-01: IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic breast cancer (MBC)

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies

artículo científico publicado en 2017

Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer

scientific article published on 09 September 2018

Antibody positron emission tomography imaging in anticancer drug development.

artículo científico

Application of PET Tracers in Molecular Imaging for Breast Cancer

artículo científico publicado en 2020

Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management

artículo científico publicado en 2020

BMI and lifetime changes in BMI and cancer mortality risk

artículo científico publicado en 2015

Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake

artículo científico publicado en 2013

Bevacizumab-induced vessel normalization hampers tumor uptake of antibodies--response.

artículo científico publicado en 2013

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

scientific article published on 04 May 2020

Comparative biodistribution analysis across four different Zr-monoclonal antibody tracers-The first step towards an imaging warehouse

artículo científico publicado en 2018

Consideration of breast cancer subtype in targeting the androgen receptor

scientific article published on 08 May 2019

Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer

artículo científico publicado en 2018

Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer

scientific article published on 07 September 2020

Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results

artículo científico publicado en 2019

Detection of Dural Metastases Before the Onset of Clinical Symptoms by 16α-[18F]Fluoro-17β-Estradiol PET in a Patient With Estrogen Receptor-Positive Breast Cancer

artículo científico publicado en 2020

Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.

artículo científico publicado en 2003

Effect of vemurafenib on a V600R melanoma brain metastasis

artículo científico publicado en 2013

Evolution in sentinel lymph node biopsy in breast cancer

artículo científico publicado en 2017

Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast

scientific article published on 25 October 2019

Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model

scientific article published on 29 September 2020

HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting

artículo científico

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

scientific article published on 18 March 2020

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

artículo científico publicado en 2020

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid

artículo científico publicado en 2015

Image Quality and Interpretation of [18F]-FES-PET: Is There any Effect of Food Intake?

artículo científico publicado en 2020

ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116

artículo científico publicado en 2014

ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment.

artículo científico publicado en 2015

Immunotherapeutic options on the horizon in breast cancer treatment.

artículo científico

In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.

artículo científico publicado en 2014

Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: a literature analysis

artículo científico publicado en 2015

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

scientific article published on 17 June 2019

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies

artículo científico publicado en 2011

Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.

artículo científico publicado en 2012

Loss of Y-Chromosome during Male Breast Carcinogenesis

artículo científico publicado en 2020

Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model

artículo científico publicado en 2012

Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer

artículo científico publicado en 2014

Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgery

artículo científico publicado en 2018

Molecular Imaging in Cancer Drug Development

artículo científico publicado en 2018

Molecular Imaging of Radiolabeled Bispecific T-Cell Engager Zr-AMG211 Targeting CEA-Positive Tumors

artículo científico publicado en 2018

Molecular imaging for monitoring treatment response in breast cancer patients.

artículo científico

Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition

scientific article published on 28 December 2019

Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets

artículo científico publicado en 2010

Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting

artículo científico publicado en 2016

PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma

artículo científico publicado en 2012

PET imaging of oestrogen receptors in patients with breast cancer

artículo científico

PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models

artículo científico publicado en 2011

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

artículo científico publicado en 2017

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy

artículo científico publicado en 2015

Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

artículo científico publicado en 2020

Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition

artículo científico publicado en 2016

Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience

artículo científico publicado en 2016

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

artículo científico publicado en 2016

Serial [<sup>18</sup>F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer

artículo científico publicado en 2020

The management of menopausal symptoms in breast cancer survivors: case-based approach.

artículo científico

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

artículo científico publicado en 2016

Transforming growth factor (TGF)-β expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging.

artículo científico

Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.

artículo científico publicado en 2016

Trastuzumab pharmacokinetics influenced by extent human epidermal growth factor receptor 2-positive tumor load.

artículo científico publicado en 2010

Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

artículo científico publicado en 2016

Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

artículo científico publicado en 2018

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

artículo científico publicado en 2016

Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.

artículo científico

Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study

scientific article published on 19 April 2020

Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.

artículo científico publicado en 2014

Web-based tailored psycho-education for breast cancer patients at the onset of the survivorship phase: a multicenter randomized controlled trial

artículo científico publicado en 2017

Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel ⬇️

artículo científico publicado el 19 de enero de 2011

[Targeted therapy: the benefit of new oncological tests]

scientific article published on 01 January 2011

Lista de obras de

(111)In-trastuzumab scintigraphy in HER2-positive metastatic breast cancer patients remains feasible during trastuzumab treatment.

(89)Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer

18F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients

89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

89Zr-bevacizumab PET imaging in primary breast cancer

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake

89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.

A 21-year-old patient with a HER2-positive colorectal cancer

Abstract OT3-2-01: IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic breast cancer (MBC)

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies

Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer

Antibody positron emission tomography imaging in anticancer drug development.

Application of PET Tracers in Molecular Imaging for Breast Cancer

Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management

BMI and lifetime changes in BMI and cancer mortality risk

Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake

Bevacizumab-induced vessel normalization hampers tumor uptake of antibodies--response.

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

Comparative biodistribution analysis across four different Zr-monoclonal antibody tracers-The first step towards an imaging warehouse

Consideration of breast cancer subtype in targeting the androgen receptor

Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer

Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer

Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results

Detection of Dural Metastases Before the Onset of Clinical Symptoms by 16α-[18F]Fluoro-17β-Estradiol PET in a Patient With Estrogen Receptor-Positive Breast Cancer

Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.

Effect of vemurafenib on a V600R melanoma brain metastasis

Evolution in sentinel lymph node biopsy in breast cancer

Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast

Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model

HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid

Image Quality and Interpretation of [18F]-FES-PET: Is There any Effect of Food Intake?

ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116

ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment.

Immunotherapeutic options on the horizon in breast cancer treatment.

In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.

Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: a literature analysis

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies

Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.

Loss of Y-Chromosome during Male Breast Carcinogenesis

Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model

Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer

Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgery

Molecular Imaging in Cancer Drug Development

Molecular Imaging of Radiolabeled Bispecific T-Cell Engager Zr-AMG211 Targeting CEA-Positive Tumors

Molecular imaging for monitoring treatment response in breast cancer patients.

Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition

Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets

Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting

PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma

PET imaging of oestrogen receptors in patients with breast cancer

PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy

Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition

Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

Serial [<sup>18</sup>F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer

The management of menopausal symptoms in breast cancer survivors: case-based approach.

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

Transforming growth factor (TGF)-β expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging.

Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.

Trastuzumab pharmacokinetics influenced by extent human epidermal growth factor receptor 2-positive tumor load.

Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.

Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study

Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.

Web-based tailored psycho-education for breast cancer patients at the onset of the survivorship phase: a multicenter randomized controlled trial

Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel ⬇️

[Targeted therapy: the benefit of new oncological tests]